Search Results

Filter
  • 1-10 of  40,660 results for ""FOSFOMYCIN""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients.

  • Authors : Oliva A; Department of Public Health and Infectious Diseases, Sapienza University of Rome. Electronic address: .; Curtolo A

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/therapeutic use ; Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacology ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/drug effects

  • Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Dec; Vol. 64 (6), pp. 107365. Date of Electronic Publication: 2024 Oct 28.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Population pharmacokinetics of oral fosfomycin calcium in healthy women.

  • Authors : Isla A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (Pharma Nano Gene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain.; Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, Vitoria-Gasteiz 01009, Spain.

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacokinetics ; Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacokinetics

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Nov 04; Vol. 79 (11), pp. 2837-2845.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Optimizing fosfomycin dosing regimens in critically ill patients with and without continuous renal replacement therapy.

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacokinetics ; Fosfomycin*/Fosfomycin*/Fosfomycin*/therapeutic use

  • Source: Journal of critical care [J Crit Care] 2025 Feb; Vol. 85, pp. 154946. Date of Electronic Publication: 2024 Nov 06.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8610642 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of fosfomycin-induced hypernatremia on patients' hospital stay length and survival.

  • Authors : Kollu K; Division of Intensive Care, Department of Internal Medicine, Konya City Hospital, University of Health Sciences, Akabe, Adana Çevre Yolu Cd. No:135/1, 42020 Karatay, Konya, Turkey. .; Bas A

Subjects: Hypernatremia*/Hypernatremia*/Hypernatremia*/mortality ; Hypernatremia*/Hypernatremia*/Hypernatremia*/chemically induced ; Length of Stay*/Length of Stay*/Length of Stay*/statistics & numerical data

  • Source: Irish journal of medical science [Ir J Med Sci] 2024 Oct; Vol. 193 (5), pp. 2453-2459. Date of Electronic Publication: 2024 May 20.Publisher: Royal Academy of Medicine of Ireland Country of Publication: Ireland NLM ID: 7806864 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Synergistic effect of fosfomycin and colistin against KPC-producing Klebsiella pneumoniae: pharmacokinetics-pharmacodynamics combined with transcriptomic approach.

  • Authors : Zhang J; Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.; Xu L

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacology ; Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacokinetics ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/drug effects

  • Source: BMC microbiology [BMC Microbiol] 2024 Oct 25; Vol. 24 (1), pp. 430. Date of Electronic Publication: 2024 Oct 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

×
Academic Journal

Intravenous fosfomycin indications and treatment outcomes in pediatric usage: analysis from a single center in Turkey.

  • Authors : Kanık-Yüksek S; Department of Pediatric Infectious Disease, University of Health Sciences, Ankara Bilkent City Hospital, Ankara 06800, Turkey.; Güneş Ö

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Fosfomycin*/Fosfomycin*/Fosfomycin*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/administration & dosage

  • Source: Journal of tropical pediatrics [J Trop Pediatr] 2024 Aug 10; Vol. 70 (5).Publisher: Oxford University Press Country of Publication: England NLM ID: 8010948 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study.

  • Authors : Belati A; Infectious Diseases Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Diella L

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/therapeutic use ; Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Gram-Negative Bacterial Infections*/Gram-Negative Bacterial Infections*/Gram-Negative Bacterial Infections*/drug therapy

  • Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Aug; Vol. 64 (2), pp. 107247. Date of Electronic Publication: 2024 Jun 19.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Optimized fosfomycin regimens for treating carbapenem-resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function.

  • Authors : Tidwong N; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.; Department of Pharmaceutical Care, Pharmaceutical Care Training Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.

Subjects: Acinetobacter baumannii*/Acinetobacter baumannii*/Acinetobacter baumannii*/drug effects ; Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacology

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Oct; Vol. 17 (10), pp. e70038.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature.

  • Authors : Butler DA; Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA.; Patel N

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacokinetics ; Fosfomycin*/Fosfomycin*/Fosfomycin*/administration & dosage ; Fosfomycin*/Fosfomycin*/Fosfomycin*/therapeutic use

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 01; Vol. 79 (10), pp. 2421-2459.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Klebsiella pneumoniae .

  • Authors : Bixby ML; University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.; Daley EC

Subjects: Fosfomycin*/Fosfomycin*/Fosfomycin*/pharmacology ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/drug effects ; Microbial Sensitivity Tests*/Microbial Sensitivity Tests*/Microbial Sensitivity Tests*/methods

  • Source: Microbiology spectrum [Microbiol Spectr] 2024 Aug 06; Vol. 12 (8), pp. e0420523. Date of Electronic Publication: 2024 Jun 28.Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  40,660 results for ""FOSFOMYCIN""